Flarex

Fluorometholone acetate

Steroid responsive allergic & other inflammatory conditions of palpebral & bulbar conjunctiva, cornea & anterior segment of eye.

Adult 1-2 drops qds. May be increased to 2 drops every 2 hr during the initial 48 hr. Elderly w/ glaucoma Max duration: 2 wk, unless longer treatment is justified.

Hypersensitivity. Vaccinia, varicella & other viral diseases of cornea & conjunctiva. Fungal diseases of ocular structure. Mycobacterial ocular infections. Untreated bacterial eye infections. Herpitic keratitis (dendritic keratitis). Infections or injuries limited to the superficial corneal epithelium. Tuberculous lesions.

Not for inj or ingestion. Upon prolonged use, risk of ocular complications & systemic side effects; growth retardation in childn; ocular HTN &/or glaucoma, w/ damage to the optic nerve, reduced visual acuity & visual field defects, & posterior subcapsular cataract formation; persistent fungal infections of the cornea; perforation of the tissues of cornea or sclera. May be accompanied by a decrease in the urinary secretion of cortisol as well as a decrease in plasma cortisol conc. May reduce infection resistance & mask clinical signs of infection. Use w/ great caution in the treatment of herpes simplex-induced stromal keratitis or uveitis. May slow corneal wound healing. Risk of flare of inflammatory conditions upon sudden treatment w/drawal. Contact lens wear is not recommended. Contains benzalkonium Cl. May affect ability to drive or use machines. Not recommended during pregnancy & in women of childbearing potential not using contraception. Lactation. Paed population <2 yr.

Uncommonly, eye irritation, ocular hyperaemia, IOP increased.

Additive IOP elevation w/ atropine & other anticholinergic eye drops. Reduced efficacy of glaucoma medications.

Eye Corticosteroids

S01BA07 - fluorometholone ; Belongs to the class of corticosteroids. Used in the treatment of inflammation of the eye.

P₁S₁S₃